Recombinant Human EPO Receptor/EPOR Protein (Fc Tag)
Recombinant Human EPO Receptor/EPOR Protein (Fc Tag) supplied by Elabscience with collaborator-provided technical specifications. Read more ›
["1. Immobilized CD131 at 10 μg/ml (100 μl/well) can bind biotinylated recombinant human EPOR with a linear range of 0.16-4 μg/ml. 2. Measured by its ability to inhibit Epodependent proliferation of TF-1 human erythroleukemic cells. The ED50 for this effect is 1-4 ng/ml in the presence of 0.1 U/mL Recombinant Human EPO. ,55-60 kDa"]Product Description
EPO Receptor/EPOR is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: Human; expression system: HEK293 Cells; physical form: Lyophilized from sterile PBS, 8% sucrose, 0.5% Tween-20, pH 7.4<br/>Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.<br/>Please refer to the specific buffer information in the printed manual.; tag: Human ,EPO Receptor/EPOR ,Recombinant Proteins; predicted molecular weight: 51.0 kDa.
Quality and formulation: purity: > 90 % as determined by reducing SDS-PAGE.; endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method..
Functional evidence: activity: 1. Immobilized CD131 at 10 μg/ml (100 μl/well) can bind biotinylated recombinant human EPOR with a linear range of 0.16-4 μg/ml. 2. Measured by its ability to inhibit Epodependent proliferation of TF-1 human erythroleukemic cells. The ED<sub>50</sub> for this effect is 1-4 ng/ml in the presence of 0.1 U/mL Recombinant Human EPO.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 51.0 kDa.
Database references: UniProt: NP_000112.1 | NCBI Gene: 2057 | Gene symbol: EPO Receptor/EPOR.
Research Use Only.
Key Facts
| Target | EPO Receptor/EPOR |
| Also known as | EPO-R |
| Species reactivity | Human |
| Purity | > 90 % as determined by reducing SDS-PAGE. |
| Form / buffer | Lyophilized from sterile PBS, 8% sucrose, 0.5% Tween-20, pH 7.4 Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
| Shelf life | 12 months |
| Research area | Signal Transduction, Cardiovascular, immunology, Stem cells |
| BIOACTIVITY | BINDING | CELL-BASED | IN VIVO | ELISA CAPTURE | |
|---|---|---|---|---|---|
| Human |
Specifications
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.